^
    Tempus HLA-LOH test is intended to identify cancer patients with solid tumors who may benefit from treatment with specific targeted therapies when tumor has experienced allele-specific loss of heterozygosity (LOH) for specific human leukocyte antigen (HLA) Class I alleles.
    Cancer:
    Solid Tumor
    Method:
    Machine learning model